Step into the world of legal psychedelics where capitalism meets mind-altering substances, promising a unique blend of innovation and controversy – a captivating journey awaits.
The Legal Psychedelics Industry: Capitalism on Drugs
Browsing Category
Technology and Science
248 posts
Twitter Says It's Experimenting With Unmentioning
Prepare to be amazed by Twitter's new experiment with unmentioning, a feature that revolutionizes online interactions – find out how it works!
Genetic Sequencing Opens New Doors and Concerns for Home Health Testing
Merging innovation with uncertainty, genetic sequencing in home health testing unlocks personalized insights while raising critical data privacy concerns.
What the Truckers' Convoy Revealed About Policing in Canada
Heralding a stark contrast in law enforcement responses, the Truckers' Convoy exposes systemic biases and prompts urgent calls for reform in Canada.
A Very Specific Kind of Brain Cell Dies off in People With Parkinson's
Sudden decline of unique brain cells linked to Parkinson's sheds light on crucial disease mechanisms.
Apple TV App on Android TV No Longer Allows Rentals, Purchases, or Subscriptions
Wondering why the Apple TV app on Android TV no longer supports transactions? Find out the implications and possible solutions ahead.
What Is Long COVID and Who's at Risk? This NIH Project May Find Out
Hoping to unravel the mysteries of Long COVID, the NIH project delves into risk factors and potential treatments, offering valuable insights.
Twitter Takes a Harder Line on POW Photos and Shadowbans Russian Government Accounts
On Twitter, a stricter stance on POW images and Russian accounts leads to unexpected consequences – find out more.
8 Ways to Know if Online Stores Are Safe and Legit
Only by following these 8 methods can you ensure online store safety and legitimacy – don't miss out on crucial tips!
Microsoft Rides the Cloud, Office, and Windows to Sustained Growth in Q3 2022
Keen to uncover how Microsoft leveraged cloud, Office, and Windows for impressive growth in Q3 2022?
